Board of Management St. Molaga's National School v The Secretary General of the Department of Education and Science

Instadose US Announces Management Transition

Retrieved on: 
Friday, January 14, 2022 - 2:32pm

Mr. Sanders will not hold any officer or director positions at Instadose US or Instadose Canada following his resignation.

Key Points: 
  • Mr. Sanders will not hold any officer or director positions at Instadose US or Instadose Canada following his resignation.
  • Mr. Sanders had committed to lead Instadose Canada through its transition to a publicly traded US company (Instadose US), as outlined in the Final Order of the Supreme Court of British Columbia approving the plan of arrangement between Instadose US and Instadose Canada.
  • During a 30-day transition period, Mr. Sanders will continue to support Instadose US and its wholly owned subsidiary (Instadose Canada) with hisin-depth knowledge of this global cannabis distribution platform.
  • Alex Wylie will assume the role of interim Chairman of Instadose US, and interim CEO of Instadose US and Instadose Canada Mr. Wylie will continue in his role as CFO of Instadose US and Instadose Canada.

HORNBACH Holding announces start of acceptance period for public delisting offer for HORNBACH Baumarkt

Retrieved on: 
Friday, January 14, 2022 - 11:35am

HORNBACH Baumarkt shareholders can accept the delisting offer by tendering their shares at an offer price of 47.50 in cash per HORNBACH Baumarkt share.

Key Points: 
  • HORNBACH Baumarkt shareholders can accept the delisting offer by tendering their shares at an offer price of 47.50 in cash per HORNBACH Baumarkt share.
  • the last close prior to the ad hoc announcement from HORNBACH Holding confirming its intention to take HORNBACH Baumarkt private.
  • HORNBACH Baumarkt shareholders who wish to accept the delisting tender offer should contact their respective custodian bank or any other securities services company where their HORNBACH Baumarkt shares are being held.
  • Albrecht Hornbach, CEO of HORNBACH Holding, says: We encourage all HORNBACH Baumarkt shareholders to accept our attractive offer prior to HORNBACH Baumarkt being delisted from the regulated market.

DGAP-News: HORNBACH Holding announces start of acceptance period for public delisting offer for HORNBACH Baumarkt

Retrieved on: 
Friday, January 14, 2022 - 11:04am

HORNBACH Holding AG & Co. KGaA ("HORNBACH Holding") announces the publication of the offer document for the public delisting tender offer to all shareholders of HORNBACH Baumarkt AG ("HORNBACH Baumarkt"), for the acquisition of all outstanding shares not already held by HORNBACH Holding, following the approval by the German Federal Financial Supervisory Authority ("BaFin").

Key Points: 
  • HORNBACH Holding AG & Co. KGaA ("HORNBACH Holding") announces the publication of the offer document for the public delisting tender offer to all shareholders of HORNBACH Baumarkt AG ("HORNBACH Baumarkt"), for the acquisition of all outstanding shares not already held by HORNBACH Holding, following the approval by the German Federal Financial Supervisory Authority ("BaFin").
  • HORNBACH Baumarkt shareholders can accept the delisting offer by tendering their shares at an offer price of 47.50 in cash per HORNBACH Baumarkt share.
  • HORNBACH Baumarkt shareholders who wish to accept the delisting tender offer should contact their respective custodian bank or any other securities services company where their HORNBACH Baumarkt shares are being held.
  • Albrecht Hornbach, CEO of HORNBACH Holding, says: "We encourage all HORNBACH Baumarkt shareholders to accept our attractive offer prior to HORNBACH Baumarkt being delisted from the regulated market.

Bayer and Mammoth Biosciences to Collaborate on Novel Gene Editing Technology

Retrieved on: 
Monday, January 10, 2022 - 7:30am

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220109005059/en/
    Mammoth Biosciences groundbreaking gene-editing technology is a key enabling technology, as well as a stand-alone therapeutic modality.
  • Were excited to be working together with Bayer, building on the technology leap of our novel CRISPR systems, along with Bayers expertise in successful drug development, said Dr. Peter Nell, Chief Business Officer and Head of Therapeutic Strategy at Mammoth.
  • Mammoth Biosciences proprietary toolkit of ultra-small Cas enzymes, including Cas14 and Cas, allows for expanded high-fidelity gene editing to be combined with targeted systemic delivery.
  • Under the agreement, Bayer gains access to this novel gene-editing technology, which offers the potential of an advanced in vivo applicability due to the ultra-compact size of these novel CRISPR systems.

Instadose Pharma Corp Ships 2.125 Metric Tons - Largest International Cannabis Delivery in History

Retrieved on: 
Wednesday, January 5, 2022 - 1:34pm

Instadose Pharma Corp delivers 2.125 Metric Tons of Medicinal Cannabis from South Africa to North Macedonia in a historic international delivery, this record-breaking shipment represents the largest Cannabis shipment globally to date.

Key Points: 
  • Instadose Pharma Corp delivers 2.125 Metric Tons of Medicinal Cannabis from South Africa to North Macedonia in a historic international delivery, this record-breaking shipment represents the largest Cannabis shipment globally to date.
  • CHESAPEAKE, Va., Jan. 5, 2022 /PRNewswire/ - (OTC PINK: INSD)Instadose Pharma Corp (the "company" or "Instadose") Establishing the world largest continual supply of Medicinal Cannabis.
  • Instadose Pharma Corp is extremely proud to announce the delivery of a record-breaking shipment of high-quality Medicinal Cannabis Flower.
  • With this successful delivery it establishes Instadose Pharma Corp as a world leader in the international supply of high quality outdoor grown medicinal cannabis and agricultural pharmaceutical ingredients.

Achiko AG Looks Back at Pivotal Year and Reaffirms Commitment to Provide Affordable and Accurate COVID-19 Testing Solution

Retrieved on: 
Thursday, December 23, 2021 - 12:30pm

The threat is clearly more evident in low- and middle-income countries, where vaccine inequality and vaccine hesitancy is greater.

Key Points: 
  • The threat is clearly more evident in low- and middle-income countries, where vaccine inequality and vaccine hesitancy is greater.
  • Results received during in-vitro trials in Spain and Indonesia indicated a greater sensitivity even at low viral loads.
  • Achiko AG (OTCQB: ACHKF; SIX: ACHI.SW; ISIN CH0522213468; www.achiko.com ) is developing disruptive diagnostic solutions that put people first.
  • Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.

EQS-News: Achiko AG looks back at pivotal year and reaffirms commitment to provide affordable and accurate Covid-19 testing solution

Retrieved on: 
Thursday, December 23, 2021 - 6:00am

"The threat is clearly more evident in low- and middle-income countries, where vaccine inequality and vaccine hesitancy is greater."

Key Points: 
  • "The threat is clearly more evident in low- and middle-income countries, where vaccine inequality and vaccine hesitancy is greater."
  • Results received during in-vitro trials in Spain and Indonesia indicated a greater sensitivity even at low viral loads.
  • The AptameX DNA aptamer tests can be rapidly chemically synthesised, are cost-effective and have wide potential across multiple disease diagnostics.
  • Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.

America First Multifamily Investors, L.P. Announces Quarterly and Special Distribution

Retrieved on: 
Tuesday, December 14, 2021 - 1:15pm

The distribution consists of a quarterly distribution of $0.11 per BUC plus a one-time special distribution of $0.08 per BUC.

Key Points: 
  • The distribution consists of a quarterly distribution of $0.11 per BUC plus a one-time special distribution of $0.08 per BUC.
  • We are very pleased that the Board declared a special distribution to close out 2021, said Kenneth C. Rogozinski, Chief Executive Officer of ATAX.
  • The aggregate amount of the distribution, including the portion representing the one-time special distribution, will be approximately $12.6 million, which will be funded by the Partnerships available cash-on-hand.
  • Greystone Manager is the general partner of America First Capital Associates Limited Partnership Two, the Partnerships general partner.

NuScale Announces James T. Hackett Has Joined the Board of Managers as Non-Executive Chairman

Retrieved on: 
Wednesday, December 15, 2021 - 9:05pm

NuScale announces today that James T. Hackett will become the non-executive Chairman of the Board of Managers for NuScale Power, LLC.

Key Points: 
  • NuScale announces today that James T. Hackett will become the non-executive Chairman of the Board of Managers for NuScale Power, LLC.
  • Hackett has served on the board of NuScale since November 2021 and as a Director on Fluor Corporations Board of Directors since 2016.
  • Hackett has several decades of executive and Board experience in the energy sector, including three current public boards.
  • Previously, Hackett served as Executive Chairman of Alta Mesa Resources, Inc., a Partner of Riverstone Holdings LLC, and Chairman and CEO of Anadarko Petroleum Corporation.

Covia Appoints New Board Member, Enhances Board Structure

Retrieved on: 
Monday, December 6, 2021 - 1:00pm

In addition, Dan Hecht has been appointed to the Board of Managers, effective November 18, 2021.

Key Points: 
  • In addition, Dan Hecht has been appointed to the Board of Managers, effective November 18, 2021.
  • In addition to his new assignment, Mr. Williams also serves on the Audit and Compensation Committees of the Board.
  • Sheets has served as a Member of the Board of Managers since December 31, 2020, and is Chair of the Audit Committee.
  • "We are pleased to welcome Dan to our Board of Managers," said Shawn Williams, Chairman of the Board and Acting Chief Executive Officer of Covia.